In Neurological Injury and Pathology In addition to NRF2s regulation of NSC physiology and function discussed above, a number of studies have revealed an important role for NRF2 in dictating NSC viability and function during stress-induced neurogenesis
Recommended Dosage and Protocol Guidelines Dosage varies by application and administration route: Skin Brightening Protocol: 6001500mg IV, 13 times per week for 812 weeks, followed by monthly maintenance Liver Detoxification Support: 6001200mg IV, 23 times per week for 48 weeks under medical supervision General Antioxidant Wellness: 600900mg IV weekly, or 5001000mg oral liposomal daily Athletic Recovery Protocol: 5001000mg IV post-training, or 500mg oral liposomal daily Heavy Metal Detox Support: 12001500mg IV, 23 times per week alongside medical chelation protocol Neurological Support Research: 10001400mg IV, frequency determined by supervising physician Reconstitution (IV use): Dissolve in 1020ml sterile saline for slow IV push over 1015 minutes Product Specifications Active Ingredient: Reduced L-Glutathione (GSH) Form: Lyophilized powder for IV reconstitution or oral liposomal capsule (variant dependent) Dose per Vial / Unit: 1500mg Purity: 99% pharmaceutical-grade (HPLC verified) Molecular Formula: CHNOS Molecular Weight: 307.32 g/mol Appearance: White crystalline lyophilized powder Solubility: Freely soluble in water and sterile saline Storage: Store at 28C
GLP-1 is a cutting-edge treatment that has been shown to: Promote weight loss: By suppressing appetite and increasing feelings of fullness
For those with hypermobility and EDS specifically, Id flag the following as the minimum due diligence before starting these medications: A thorough GI history and ideally gastric emptying assessment if theres any existing dysmotility Baseline muscle mass measurement (DEXA or similar) given the sarcopenia risk A clear plan for high-protein diet and resistance-based exercise to mitigate muscle loss Baseline bone density if theres any existing concern Consideration of the nutritional picture specific to hypermobility, since these drugs can affect appetite and nutrient absorption A conversation specifically about MCAS if thats a feature of your presentation The medication options for hypermobility and EDS are limited and often unsatisfying, and its entirely understandable why people are looking at something new with genuine curiosity
